Stocks
Harvard Apparatus Regenerative Technology Inc.HRGN
OQBHealthcareBiotechnology$2.23
Price as of · delayed, not real-time
A regenerative medicine company developing medical devices and therapies for organ and tissue repair, with a focus on tissue engineering and cell-based treatments. Its lead platform targets esophageal and vascular reconstruction, and investors track it for its early-stage clinical pipeline and potential in the regenerative medicine market.
52W Range: $0.96-$2.46
Congressional Interest in Harvard Apparatus Regenerative Technology Inc. (HRGN)
No congressional trades have been disclosed for Harvard Apparatus Regenerative Technology Inc. (HRGN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HRGN?
No congressional trades found for this stock.